Prognostic significance of POLE exonuclease domain mutations in high grade endometrioid endometrial cancer on survival and recurrence

被引：0
|
作者：
Billingsley, C. C. [1 ]
Hade, E. M. [2 ]
Cohn, D. E. [1 ]
Mutch, D. G. [3 ]
Goodfellow, P. J. [1 ]
机构：
[1] Ohio State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Obstet & Gynecol, Biostat, Columbus, OH 43210 USA
[3] Washington Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2015.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：591 / 592
页数：2
相关论文
共 50 条
  • [21] Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma
    Wang, Jieyu
    Jia, Nan
    Li, Qing
    Wang, Chao
    Tao, Xiang
    Hua, Keqin
    Feng, Weiwei
    ONCOLOGY LETTERS, 2016, 12 (04) : 2860 - 2867
  • [22] Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
    Hussein, Yaser R.
    Weigelt, Britta
    Levine, Douglas A.
    Schoolmeester, J. Kenneth
    Dao, Linda N.
    Balzer, Bonnie L.
    Liles, Georgia
    Karlan, Beth
    Koebel, Martin
    Lee, Cheng-Han
    Soslow, Robert A.
    MODERN PATHOLOGY, 2015, 28 (04) : 505 - 514
  • [23] Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis
    Espinosa, Inigo
    Lee, Cheng-Han
    D'Angelo, Emanuela
    Palacios, Jose
    Prat, Jaime
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (08) : 1121 - 1128
  • [24] Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer
    Dobrzycka, Bozena
    Jerzy, Terlikowski Slawomir
    Kwiatkowski, Marcin
    Magdalena, Garbowicz
    Kinalski, Maciej
    Chyczewski, Lech
    GINEKOLOGIA POLSKA, 2010, 81 (06) : 422 - 425
  • [25] Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival
    Lee, So Jung
    Kang, Hye Jin
    Kwak, Yoo-Kang
    Kim, Myungsoo
    Kim, Jisang
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (09) : 828 - 837
  • [26] Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival
    So Jung Lee
    Hye Jin Kang
    Yoo-Kang Kwak
    Myungsoo Kim
    Jisang Kim
    Strahlentherapie und Onkologie, 2023, 199 : 828 - 837
  • [27] POLE gene mutations confer good progression free survival in Asian women with FIGO grade 3 endometrioid endometrial carcinoma
    Wong, Adele
    Kuick, Chik Hong
    Wong, Wai Loong
    Them, Jill M.
    Mansor, Sorsiah
    Eva, Loh
    Jain, Sudhanshi
    Chan, Sock Hoai
    Tan, Sze Huey
    Li, Shao Tzu
    Vikas, Nadkarni N.
    Chew, Sung Hock
    Ngeow, Joanne
    Hong, Wanjin
    CANCER RESEARCH, 2016, 76
  • [28] Pathogenic TP53 Mutations in Advanced/Recurrent Endometrial Carcinoma with Pathogenic POLE Exonuclease Domain Mutations
    Bai, Lixia
    Lamb, Laura
    Mowers, Jonathan
    Weisman, Paul
    Tomlins, Scott
    McGregor, Stephanie
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1108 - S1108
  • [29] Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer
    Wilczynski, Milosz
    Danielska, Justyna
    Dzieniecka, Monika
    Szymanska, Bozena
    Wojciechowski, Michal
    Malinowski, Andrzej
    PLOS ONE, 2016, 11 (10):
  • [30] Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
    Han, K. H.
    Kim, H. S.
    Song, Y. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 990 - 990
12345